ChristopherEllisCollinsMD
Rheumatology • Washington, DCLupus & Related, Rheumatoid Arthritis & Related, Spondyloarthropathy, Vasculitis
Associate Professor of Medicine, Georgetown University Medical Center Associate Program Director, Washington Hospital Center Division of Rheumatology
Dr. Collins is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
110 Irving St Nw # 2a52
Washington, DC 20010Phone+1 202-877-6274Fax+1 202-877-6130- Is this information wrong?
Education & Training
National Institutes of Health Clinical CenterFellowship, Rheumatology, 2007
U Southern California2005
University of Southern California/LAC+USC Medical CenterResidency, Internal Medicine, 2000 - 2003- University of Southern California/LAC+USC Medical CenterInternship, Internal Medicine, 2000 - 2001
University of Arkansas For Medical Sciences College of MedicineClass of 2000
Certifications & Licensure
CA State Medical License 2001 - Present
DC State Medical License 2006 - 2020
Awards, Honors, & Recognition
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- 5 citationsA Multianalyte Assay Panel With Cell-Bound Complement Activation Products Predicts Transition of Probable Lupus to American College of Rheumatology-Classified Lupus.Rosalind Ramsey-Goldman, Roberta Vezza Alexander, John Conklin, Cristina Arriens, Sonali Narain, Elena Massarotti, Daniel J. Wallace, Christopher E Collins, Amit Saxen...> ;ACR Open Rheumatology. 2021 Feb 4
- 24 citationsReal-World Effectiveness of Belimumab in the Treatment of Systemic Lupus Erythematosus: Pooled Analysis of Multi-Country Data from the OBSErve Studies.Christopher E Collins, Josefina Cortés-Hernández, Mercedes A. Garcia, Johannes von Kempis, Andreas Schwarting, Zahi Touma, Milena Kurtinecz, Kerry Gairy> ;Rheumatology and Therapy. 2020 Nov 18
- 6 citationsCell-bound complement activation products associate with lupus severity in SLE.Cristina Arriens, Roberta Vezza Alexander, Sonali Narain, Amit Saxena, Christopher E Collins, Daniel J. Wallace, Elena Massarotti, John Conklin, Kenneth C. Kalunian, C...> ;Lupus Science & Medicine. 2020 Apr 1
- Join now to see all
Press Mentions
Complement Activation in Patients with Probable Lupus and Ability to Predict ProgressionJanuary 16th, 2020
Osteoarthritis Risk Factors and Causes You Need to Know AboutNovember 18th, 2019- 10 Lupus Complications You Need to Know AboutJuly 24th, 2019
Professional Memberships
- Fellow
Hospital Affiliations
MedStar Washington Hospital CenterWashington, District of Columbia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
